|
|
Global Neuroblastoma Drug Pipeline Capsule - 2011 |
|
Request for Sample Pages |
| Published Date : 23 August 2011 |
|
|
|
Pages : 13 |
|
| |
|
|
|
|
|
|
|
Fore Pharmas latest report ‘Global Neuroblastoma Drug Pipeline Capsule – 2011
is an outline of all the key research and development (R&D) activities of the
global neuroblastoma drug market. It covers information on key pipeline
molecules in various stages of R&D including all the phases of clinical trials,
preclinical research, and drug discovery. The report is up-to-date with full
coverage of the licensing activities and partnerships.
This report helps executives to keep a track of their competitors and understand
their pipeline molecules. The information presented in this report can be used
for identifying the partners, prioritizing, evaluating opportunities, developing
business development strategies, and executing in-licensing and out-licensing
deals.
The report provides information on pipeline molecules by company and mechanism
of action across the different stages of R&D. It includes registered /
preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1
clinical trial, preclinical research, and drug discovery. It also provides
information on pipeline molecules developed in leading geographies including the
U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D.
Licensing activities and partnerships in the neuroblastoma drug market is
thoroughly covered by company and licensee with the deal summary.
Key Features of the Report:
- Neuroblastoma: Overview
- Neuroblastoma Drug Pipeline Overview
- Neuroblastoma Phase 3 Clinical Trial Drug Pipeline Insights
- Neuroblastoma Phase 2 Clinical Trial Drug Pipeline Insights
- Neuroblastoma Phase 1 Clinical Trial Drug Pipeline Insights
- Neuroblastoma Preclinical Research Drug Pipeline Insights
- Neuroblastoma Drug Discovery Pipeline Insights
- Geographic Landscape of Neuroblastoma R&D Activities
- Neuroblastoma R&D Activities in North America
- Neuroblastoma R&D Activities in Europe
- Licensing Activities / Partnerships in the Global Neuroblastoma Drug Market
|
|
|
|
Table of Contents : |
| 1.
Neuroblastoma: Disease Definition
2. Neuroblastoma Drug Pipeline Overview
3. Neuroblastoma Phase 3 Clinical Trial Drug Pipeline Insights
4. Neuroblastoma Phase 2 Clinical Trial Drug Pipeline Insights
5. Neuroblastoma Phase 1 Clinical Trial Drug Pipeline Insights
6. Neuroblastoma Preclinical Research Drug Pipeline Insights
7. Neuroblastoma Drug Discovery Pipeline Insights
8. Geographic Landscape of Neuroblastoma R&D Activities
8.1 Neuroblastoma R&D Activities in North America
8.2 Neuroblastoma R&D Activities in Europe
9 Licensing Activities / Partnerships in the Global Neuroblastoma Drug
Market
10 Research Methodology |
Table 1: Neuroblastoma Drug
Pipeline: Phase 3 Clinical Trial
Table 2: Neuroblastoma Drug Pipeline: Phase 2 Clinical Trial
Table 3: Neuroblastoma Drug Pipeline: Phase 1 Molecules
Table 4: Neuroblastoma Drug Pipeline: Preclinical Research
Table 5: Neuroblastoma R&D Activities by Geography
Table 6: Neuroblastoma Drug Pipeline: North America
Table 7: Neuroblastoma Drug Pipeline: Europe
Table 8: Neuroblastoma Drug Pipeline: Licensing Activities
|
Figure
1 : Neuroblastoma Drug Pipeline Molecules by Stages
Figure 2 : Neuroblastoma R&D Activities by Geography |
|
|
|
Published By : Fore Pharma |
|
|
Category
Related Report:
Automotive,
Automobile,
Aerospace & Aviation,
Banking,
Consumer Goods,
Construction,
Chemicals,
Defense,
Diabetes,
Disease,
Drinks,
Energy,
Electronics,
Financial
,
Food & Drinks,
Glass,
Healthcare,
Insurance,
Information technology,
Investment,
Industrial Gases,
Industry Profile,
Medical,
Media,
Marketing,
Miscellaneous,
Metals & Mining,
Nuclear Energy,
Oil & Gas,
Power,
Real Estate,
Software,
Solar,
Transportation
|
|
|
|
